All Posts

Other5 min read

Rules Engines in Healthcare: Supporting Care Decisions Without Replacing the Clinician

Rules Engines in Healthcare: Supporting Care Decisions Without Replacing the Clinician

Key Takeaways

  • Rules engines apply explicit logic, such as guidelines, benefit rules and protocols, consistently and in real time.
  • The clearest automation opportunities are administrative: eligibility, benefits, prior authorization, routing and outreach.
  • In clinical care, rules support clinicians; they should not make treatment decisions on their own.
  • FDA’s clinical decision support guidance, revised in January 2026, sets the line: software that lets a clinician independently review the basis for a recommendation can fall outside device regulation; software the clinician must rely on generally does not.
  • CMS’s prior authorization rule has required specific denial reasons and faster decisions from certain payers since January 1, 2026.

What Is a Rules Engine in Healthcare?

A rules engine is software that applies explicit if-then logic to data and returns a result, such as an alert, a recommendation, a routing decision or an approval. In healthcare, the rules come from clinical guidelines, payer policies, benefit designs and internal protocols.

Rules engines are often confused with AI. They are different tools. A rule does exactly what it says, and its logic can be read and checked. A machine learning model estimates a probability from patterns in data. Many healthcare systems use both. For the fundamentals, see What Is a Rules Engine?

Where Do Rules Engines Help in Healthcare?

The use cases fall into two groups with very different risk profiles:

Area Example decisions Who decides
Eligibility and benefits Is the member covered for this service? Which cost-sharing applies? Rules can decide, with appeal paths
Prior authorization Does the request meet documented criteria? Which requests need clinical review? Rules approve or route; clinicians review denials
Claims and billing Does the claim match the fee schedule and coding rules? Rules decide routine cases; staff review exceptions
Care management outreach Which members are due for a screening or follow-up? Rules trigger outreach; care teams act
Appointment and refill reminders When should a reminder go out, and through which channel? Rules decide
Clinical decision support Drug interaction alerts, guideline reminders, dosing checks Rules support; the clinician decides

The same kind of logic appears in P&C insurance. Workers’ compensation and auto medical claims are checked against fee schedules and treatment guidelines that vary by state, which is a typical rules engine task in claims operations.

What Changed for Prior Authorization in 2026?

The CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F) applies to Medicare Advantage organizations, state Medicaid and CHIP fee-for-service programs, Medicaid managed care plans, CHIP managed care entities and Qualified Health Plan issuers on the federally facilitated exchanges. Starting in 2026, these payers must:

  • Send prior authorization decisions within 72 hours for expedited requests and seven calendar days for standard requests.
  • Give a specific reason for denied prior authorization decisions, regardless of how the decision was made.
  • Publicly report prior authorization metrics each year, with the first metrics due by March 31, 2026.

API requirements for prior authorization and data exchange generally apply from January 1, 2027 (CMS, January 2024).

These requirements favor rules that are explicit and logged. When a payer must state a specific denial reason within a fixed deadline, criteria kept in readable, versioned rules are easier to apply and defend than criteria scattered across documents and reviewers’ notes.

Where Is the Line Between Decision Support and a Medical Device?

In the United States, the 21st Century Cures Act excludes certain clinical decision support (CDS) software from the definition of a medical device. FDA’s guidance, revised on January 6, 2026, applies four criteria. Non-device CDS software:

  1. does not acquire, process or analyze a medical image or a signal from an in vitro diagnostic device or a signal acquisition system;
  2. displays, analyzes or prints medical information;
  3. supports or provides recommendations to a healthcare professional about prevention, diagnosis or treatment;
  4. enables the professional to independently review the basis for the recommendation, so that they do not rely primarily on it.

The 2026 revision lets FDA exercise enforcement discretion for tools that give a single recommendation when only one is clinically appropriate. Software for time-critical decisions still cannot meet the non-device criteria (Covington, January 2026).

For rules engines, the practical point is the fourth criterion. Transparent rules make it possible to show a clinician why an alert fired: which guideline, which threshold, which data. That transparency is part of what keeps decision support in a supporting role. Whether a specific product is a device is a regulatory question for the developer and its counsel, not something a technology choice settles.

How Do Rules Support Clinical Decisions in Practice?

Common rule-based CDS functions include:

  • Medication checks. Alerts for drug interactions, allergies, duplicate therapy and doses outside a range, shown with the rule and data that triggered them.
  • Guideline reminders. Prompts when a patient is due for a screening, vaccination or lab test under the organization’s adopted guidelines.
  • Risk stratification. Sorting patients into outreach or monitoring groups based on documented criteria, so care teams know whom to contact first.
  • Care pathway suggestions. Showing the pathway the organization’s protocol recommends for a diagnosis, while leaving the decision to the clinician.

Two design rules make these tools useful rather than noisy. First, alerts need to be specific and rare enough that clinicians do not start ignoring them. Second, every alert should show its basis, so the clinician can judge whether it applies to this patient.

How Do Rules and Machine Learning Work Together in Healthcare?

Machine learning can find patterns that rules cannot express easily, such as early signs of deterioration or likely readmission. Rules are better at applying policy and explaining it.

A common pattern: the model scores, the rules decide what happens next, and a clinician stays in the loop. A readmission model returns a risk score; rules decide whether the patient enters a care management program or gets a follow-up call; the care team reviews and acts. Advanced uses such as imaging analysis or genomics-based treatment selection sit in regulated device territory and need their own validation.

What Should You Plan for When You Implement a Rules Engine?

  • Data protection. Health data falls under HIPAA. Plan access control, encryption, audit logs and business associate agreements from the start.

  • Integration. Most clinical data lives in the EHR and most payer data in core administration systems. The rules engine needs clean, timely inputs through APIs.

  • Rule ownership. Every rule needs a clinical or policy owner, a source (guideline, policy, contract) and a review date.

  • Testing. Run rule changes against historical cases before release and check how many alerts or decisions change.

  • Version history. For any past decision, you should be able to show which rule version applied.

  • Human oversight. Define which decisions rules may take alone, which they may only recommend, and how people override them.

Where Does Higson Fit?

Higson is a business rules engine built by Decerto for insurance and financial services, used mainly by P&C insurers for product configuration, underwriting, pricing and claims rules. It is not a medical device, an EHR or a clinical decision support product, and it has no FDA clearance.

The capabilities that matter in claims operations apply to any rule-heavy process: decision tables that business teams maintain, testing before production, versioning with rollback, a full audit trail, rule execution at 0.23 ms per decision, and an ONNX runtime for running your own ML models inside rules. For P&C carriers, that includes checking medical bills in workers’ compensation and auto claims against state fee schedules and internal guidelines.

‍

Sources

  1. FDA, Clinical Decision Support Software - guidance (strona FDA) - https://www.fda.gov/regulatory-information/search-fda-guidance-documents/clinical-decision-support-software
  2. Covington & Burling, „5 Key Takeaways from FDA’s Revised Clinical Decision Support (CDS) Software Guidance”, I 2026 (wytyczne z 6.01.2026) - https://www.cov.com/en/news-and-insights/insights/2026/01/5-key-takeaways-from-fdas-revised-clinical-decision-support-cds-software-guidance
  3. CMS, fact sheet „CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F)“, 17.01.2024 - https://www.cms.gov/newsroom/fact-sheets/cms-interoperability-prior-authorization-final-rule-cms-0057-f

Take Full Control of Your Product Logic

We provide fee Proof Of Concept, so you can see how Higson can work with your individual business logic.